1. 17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5
- Author
-
Friedrich Stock, Natascha Roehlen, Birgitta Gläser, Jochen Seufert, Johannes Guhl, Katharina Laubner, Annette Schmitt-Graeff, and Hanna Hilger
- Subjects
Adult ,0301 basic medicine ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,030209 endocrinology & metabolism ,Context (language use) ,Bioinformatics ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Central Nervous System Diseases ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Deletion syndrome ,Sex organ ,Stage (cooking) ,Dental Enamel ,Hepatocyte Nuclear Factor 1-beta ,business.industry ,Biochemistry (medical) ,Syndrome ,Kidney Diseases, Cystic ,medicine.disease ,HNF1B ,030104 developmental biology ,Diabetes Mellitus, Type 2 ,Chromosomal region ,Hepatocyte Nuclear Factor 1-Beta ,Female ,Chromosome Deletion ,business ,Chromosomes, Human, Pair 17 - Abstract
Context Maturity-onset diabetes of the young type 5 (MODY5) is caused by mutations of the hepatocyte nuclear factor 1 homeobox β gene (HNF1B). Although clinical characteristics and therapeutic management of MODY5 are increasingly better defined, adequate consideration of the frequent association of MODY5 with 17q12 deletion syndrome is often missing. Evidence Acquisition We report two cases of patients with 17q12 deletion syndrome who presented to our clinic. Furthermore, we reviewed the existing literature to improve systematic diagnostic and therapeutic approaches. A PubMed search using the terms 17q12 deletion syndrome, diabetes mellitus type MODY5, and/or HNF1B was performed. Evidence Synthesis Three hundred sixty-one cases of postnatal 17q12 deletion syndrome were assessed, and details on clinical manifestations, diagnostic approaches, and therapeutic management were reviewed and compared with the two cases at our clinic. Furthermore, data on pathogenic mechanisms and their clinical implications were evaluated. Conclusion The 17q12 deletion syndrome usually comprises MODY5, structural or functional abnormalities of the kidneys, and neurodevelopmental or neuropsychiatric disorders. A complete deletion of HNF1B can be found in about 50% of patients with MODY5. A wide variety of additional clinical features, including genital and brain malformations, has been reported. Because HNF1B deletions are virtually always part of a 17q12 deletion syndrome and common genetic analyses for evaluation of MODY5 are unable to detect the deletion of a 1.4-Mb chromosomal region, initial attention to the syndromal features at the stage of diagnosis is of considerable importance for establishing correct diagnosis, subsequent therapy, and interdisciplinary patient care.
- Published
- 2018
- Full Text
- View/download PDF